Search results
Man receives world’s first melanoma vaccine — trial underway
New York Post· 1 day agoThe Phase 3 trial hopes to recruit 1,100 people. The vaccine, called mRNA-4157 (V940) works...
Covid-19 Vaccination Associated With Reductions In Pediatric Cases And Hospitalizations
Forbes· 3 days agoA California-based study found that thanks to the state’s Covid-19 immunization program, there was a...
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights
Reuters· 2 days agoBiotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit...
COVID-19 kills 2 more in N.B., flu sends child under 4 and 2 youths to hospital
CBC via Yahoo News· 5 days agoCOVID-19 has killed two more New Brunswickers, while a child under four and two youths aged five to ...
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National...
Morningstar· 6 days ago(NASDAQ:MRNA) today announced a contract with the Ministry of Health in Brazil (Ministério da Saúde) to supply its mRNA COVID-19 vaccine
AstraZeneca confirms strong vaccine protection after US rift
AOL· 4 days agoAstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional...
Maine high court says EMS Board had authority to impose vaccine mandate
Bangor Daily News· 2 days agoMaine’s highest court has ruled a state board overseeing emergency medical service workers had the...
Can nasal Neosporin fight COVID? Surprising new research suggests it works
Salon.com· 20 hours agoFour years ago, when COVID-19 first began to spread globally, it didn't just damage our physical...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 5 days agoThe pair won the 2023 Nobel Prize in Medicine for discoveries that were “critical for developing...
...Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 4 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...